LATEST PSYCHEDELICS STOCKS NEWS

Revive Therapeutics Update Following U.S. FDA Approval of Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 05, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that following the U.S. Food & Drug Administration (“U.S. FDA”) approval to procee... Read More...

Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule

Toronto, Ontario--(Newsfile Corp. - August 5, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) ("Red Light Holland" or the "Company"), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a its brand of magic truffles to the legal, recreational market within the Netherlands (initially, in t... Read More...

Hollister Biosciences Inc. and Heavy Brands Inc. Enter into Letter of Intent for Proposed Joint Venture Agreement

Hollister Biosciences Inc., the creator of California's most hash-infused pre-roll HashBone, is pleased to announce that it's entered into a letter of intent to manufacture pre-rolls for some of the biggest names in rock and metal music.VANCOUVER, BC, Aug. 5, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the... Read More...

Nutritional High Announces Settlement of Payables and Update on Psychedelic Sciences Corp Acquisition.

Toronto, Ontario--(Newsfile Corp. - August 4, 2020) - Nutritional High International Inc. (CSE: EAT) (OTC Pink: SPLIF) ("Nutritional High" or the "Company") is pleased to announce settlement of trade payables and an update regarding the acquisition of Psychedelic Sciences Corp ("PSC").The Company announces that trade creditors representin... Read More...

Osoyoos Closes Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - August 4, 2020) - Osoyoos Cannabis Inc. (CSE: OSO) ("Osoyoos" or the "Company") is pleased to announce that the Company has closed its previously announced non-brokered private placement (the "Private Placement") of up to 20,000,000 units of the Company (the "Units"), at a price of $0.05 per Unit, for g... Read More...

Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness

DENVER, Aug. 04, 2020 -- Mydecine Innovations Group™ (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) ("Mydecine"), is pleased to announce that its subsidiary, Mindleap Health™ (“Mindleap” or the “Company”) based in Vancouver, British Columbia, is expanding it’s digital therapeutic offerings by adding three additional programs to its platform.Mindleap™... Read More...

UPDATE – Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, July 31, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV) (OTCQB: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food & Drug Administration (“U.S. FDA”) has approved the Company ... Read More...

Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, July 31, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food & Drug Administration (“U.S. FDA”) has approved the Company to proceed with... Read More...

BetterLife Pharma Receives Approval from Altum Pharmaceuticals Inc. Shareholders to Complete Merger

Vancouver, July 30, 2020 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company with proprietary interferon-based therapeutic technologies, is pleased to provide an update on the results of the Special Meeting of the shareholders of Altum Pharmaceuticals Inc. (“A... Read More...

Yield Growth Closes $1.4 Million Financing

Vancouver, British Columbia--(Newsfile Corp. - July 30, 2020) - The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) (the "Company") announces that it has closed financings totalling $1.4 million this week. The financing consisted of $700,000 in units offered through a shelf prospectus supplement at a price of $0.10 per unit (each... Read More...

MindMed Completes Dosing 18-MC Phase 1 Study

Company, seeing early success, will advance preparations for Phase 2a clinical trial in opioid addictionNEW YORK, July 28, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has concluded dosing in a Phase 1 Single Ascending Dose (SAD) study of 18-MC. The dosing of 18-MC was well... Read More...

Captiva Verde Announces Esmeralda Agreement with Mexican Health Care Workers Union for up to USD$142 Million per Year of Annual Product Sales

Coquitlam, British Columbia--(Newsfile Corp. - July 27, 2020) - Captiva Verde Land Corp. (CSE: PWR) (OTC: CPIVF) (the "Company" or "Captiva Verde"), is pleased to announce that further to its news release of October 2, 2019, where Captiva Verde has executed a share exchange agreement to acquire Salud Esmeralda de Mexico SA de CV, ("Esmera... Read More...

GreenStar Biosciences Completes Acquisition of 100% of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer

Strategic acquisition by GreenStar adds innovative company focused on the development of effective therapeutics using psychedelic medicineVancouver, British Columbia--(Newsfile Corp. - July 27, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press rele... Read More...

BetterLife Pharma Provides Update on Proposed Acquisition of Altum and its Regulatory Guidance and Updated Clinical Development Plan

VANCOUVER, BC, July 27, 2020 - BetterLife Pharma Inc. ("BetterLife") (CSE: BETR) (OTCQB: BETRF) (FRA: NPAT) is pleased to provide an update on the proposed acquisition of Altum Pharmaceuticals Inc. ("Altum") and its upcoming clinical programs. A Special Meeting of Altum shareholders, more than 72% of whom have signed a Lock Up Agreement, ... Read More...

Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

VANCOUVER, British Columbia, July 24, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) is pleased to announce it has filed business acquisition reports in connection with its previous acquisitions of Artisan Growers Ltd., Novo Formulations Ltd. and Tassili Life Sciences Corp. Copies of t... Read More...

Empower Clinics Reports Fiscal 2019 Results

VANCOUVER, BC / ACCESSWIRE / July 24, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTC PINK:EPWCF)(Frankfurt:8EC)("Empower" or the "Company") has filed today its audited consolidated financial statements and related management's discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this press releas... Read More...

BetterLife CEO Discusses Merger, Planned Interferon Treatment Trials and Potential Subsequent FDA Emergency Use Authorization

New York City, July 23, 2020 -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRD) (CSE:BETR), an emerging biotechnology company currently preparing its own interferon-based coronavirus treatment clinical trials, recently joined online portal Proactive for a Q&A which included the upcoming merger with Altum Pharmaceu... Read More...

Red Light Holland Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - July 22, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) ("Red Light Holland" or the "Company"), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased t... Read More...

Mota Ventures Announces European Expansion Through Joint Venture Agreement with Franchise Cannabis

VANCOUVER, BC / ACCESSWIRE / July 22, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ)(OTC PINK:PEMTF) (the "Company" or "Mota Ventures") is pleased to announce it has entered into a binding agreement (the "Transaction Agreement") dated July 21, 2020, with Franchise Cannabis Corp. ("Franchise") to form a joint venture in Europe ("European J... Read More...

GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

Strategic acquisition by GreenStar to add innovative company focused on the development of effective therapeutics using psychedelic medicineVancouver, British Columbia--(Newsfile Corp. - July 21, 2020) -  GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press r... Read More...

Red Light Holland Announces Live Investor Q&A Session Featuring Russell Peters and Bruce Linton on Instagram Live at 2 PM (E.S.T.) on Friday, July 31, 2020

Toronto, Ontario--(Newsfile Corp. - July 21, 2020) - Red Light Holland Corp.(CSE: TRIP) (FSE: 4YX) ("Red Light Holland" or the "Company"), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to... Read More...

Nutritional High Announces Closing of Psychedelic Science Corp’s Private Placement of Units

Toronto, Ontario--(Newsfile Corp. - July 21, 2020) - Nutritional High International Inc. (CSE: EAT) ("Nutritional High" or, the "Company") is pleased to announce that Psychedelic Science Corp. ("PSC") has closed a non-brokered private placement (the "Offering") for aggregate gross proceeds of $1,035,689 through the issuance 34,522,968 uni... Read More...

IntelGenx and Tilray® Agree to Amend Certain Exclusivity Terms of Worldwide Cannabis-Infused VersaFilm® Agreement

SAINT LAURENT, Quebec, July 20, 2020 -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it and Tilray, Inc. (“Tilray®”) have amended the exclusivity terms of their November 2018 license, development and supply agreement (the “Agreement”) to allow for IntelGenx’s co-development and commercializat... Read More...

PharmaDrug Inc. Repays Amounts Owing Under Bridge Loan and Advisory Agreement, Completes Previously Announced Debt Restructuring and Provides Financial Update

Toronto, Ontario--(Newsfile Corp. - July 17, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that it has repaid amounts owing by the Company to the lender (inclusive of interest and fees) pursuant to a bridge loan (the "Bridge Loan") and amounts owing to a financial advisor under an ... Read More...

Red Light Holland Engages Radixmotion to Develop an Innovative Virtual Reality Shopping Experience for Dutch Smart Shops and e-Commerce Platforms

Toronto, Ontario--(Newsfile Corp. - July 17, 2020) - Red Light Holland Corp. (CSE:TRIP) (FSE:4YX) ("Red Light Holland" or the "Company"), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to ... Read More...

Red Light Holland Announces Closing of Final Tranche of Fully Subscribed Private Placement Including Strategic Mutual Investment with PharmaDrug

Toronto, Ontario--(Newsfile Corp. - July 16, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) ("Red Light Holland" or the "Company"), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased t... Read More...